Security key
48115J109
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 21,352,124
- Total 13F shares
- 2,156,982
- Share change
- -211,945
- Total reported value
- $12,186,357
- Price per share
- $5.65
- Number of holders
- 36
- Value change
- -$1,194,242
- Number of buys
- 13
- Number of sells
- 14
Report period
Q3 2024
Institutions
36
Top holders
10
DERM full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Top shareholders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
310,248
|
$1,749,799 | — | 30 Jun 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
1.4%
|
294,950
|
$1,664,000 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
264,025
|
$1,489,101 | — | 30 Jun 2024 | |
| AMERICAN FINANCIAL GROUP INC |
13F
|
Company |
0.84%
|
180,000
|
$1,015,000 | — | 30 Jun 2024 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.74%
|
158,540
|
$894,165 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
148,322
|
$836,536 | — | 30 Jun 2024 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.62%
|
131,571
|
$742,060 | — | 30 Jun 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.53%
|
114,132
|
$643,704 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
95,553
|
$539,047 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.44%
|
94,404
|
$531,000 | — | 30 Jun 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.32%
|
68,294
|
$385,178 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.3%
|
63,579
|
$358,586 | — | 30 Jun 2024 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.3%
|
63,280
|
$356,899 | — | 30 Jun 2024 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.29%
|
61,350
|
$346,014 | — | 30 Jun 2024 | |
| Atria Investments, Inc |
13F
|
Company |
0.26%
|
55,337
|
$312,101 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.24%
|
51,864
|
$292,513 | — | 30 Jun 2024 | |
| Gladstone Institutional Advisory LLC |
13F
|
Company |
0.16%
|
33,481
|
$188,833 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
25,553
|
$144,119 | — | 30 Jun 2024 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.11%
|
23,020
|
$129,833 | — | 30 Jun 2024 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.1%
|
22,000
|
$124,000 | — | 30 Jun 2024 | |
| Cetera Investment Advisers |
13F
|
Company |
0.09%
|
18,613
|
$104,977 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
17,654
|
$99,569 | — | 30 Jun 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.06%
|
12,654
|
$71,369 | — | 30 Jun 2024 | |
| Creative Planning |
13F
|
Company |
0.06%
|
11,764
|
$66,349 | — | 30 Jun 2024 | |
| TMD Wealth Management, LLC |
13F
|
Company |
0.05%
|
11,605
|
$65,452 | — | 30 Jun 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
10,542
|
$59,000 | — | 30 Jun 2024 | |
| Allegiance Financial Group Advisory Services LLC |
13F
|
Company |
0.05%
|
10,000
|
$56,400 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
4,933
|
$27,822 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
1,329
|
$7,496 | — | 30 Jun 2024 | |
| Transcendent Capital Group LLC |
13F
|
Company |
0%
|
500
|
$2,820 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
400
|
$2,256 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
371
|
$2,000 | — | 30 Jun 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
300
|
$1,692 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
71
|
$400 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
20
|
$113 | — | 30 Jun 2024 | |
| Fortress Biotech, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,860,467
|
$11,735,820 | — | 12 May 2022 | |
| Ernest Robert de Paolantonio |
3/4/5
|
Officer |
—
class O/S missing
|
259,907
|
$1,356,715 | — | 04 Oct 2022 | |
| Jeffrey Paley |
3/4/5
|
Director |
—
class O/S missing
|
70,727
|
$369,195 | — | 28 Nov 2023 |
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q3 2024
As of 30 Sep 2024,
Journey Medical Corp - Common Stock (DERM) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,156,982 shares.
The largest 10 holders included
VANGUARD GROUP INC, Cambridge Investment Research Advisors, Inc., RENAISSANCE TECHNOLOGIES LLC, AMERICAN FINANCIAL GROUP INC, PVG ASSET MANAGEMENT CORP, ENVESTNET ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Rosalind Advisors, Inc., NEUBERGER BERMAN GROUP LLC, and Geneos Wealth Management Inc..
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
35
Q3 2024 holders
36
Holder diff
1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.